Fair Meadow Nursing Home in Fertile, MN

Fair Meadow Nursing Home is a medicare and medicaid certified nursing home in Fertile, Minnesota. It is located in Polk county at 300 Garfield Avenue Southeast, Fertile, Minnesota 56540. You can reach out to the office of Fair Meadow Nursing Home via phone at (218) 945-6194. This skilled nursing facility has 42 federally certified beds with average occupancy rate of 92.38%. Its legal business name is Village Of Fertile and has the following ownership type - Government - City.

Fair Meadow Nursing Home (Medicare CCN 245545) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1991 (33 years certified) and the last quality survey was conducted in June, 2019.

Contact Information

Fair Meadow Nursing Home
300 Garfield Avenue Southeast, Fertile, Minnesota 56540
(218) 945-6194


Nursing Home Profile

NameFair Meadow Nursing Home
Location300 Garfield Avenue Southeast, Fertile, Minnesota
Certified ByMedicare and Medicaid
No. of Certified Beds42
Occupancy Rate92.38%
Medicare ID (CCN)245545
Legal Business NameVillage Of Fertile
Ownership TypeGovernment - City

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Fair Meadow Nursing Home from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1417950593
Organization NameVILLAGE OF FERTILE
Doing Business AsFAIR MEADOW NURSING HOME
Address300 Garfield Ave. Se, Fertile, MN 56540
Phone Number218-945-6194

News Archive

Boehringer to present data of SOUND-C1 Phase Ib study for HCV treatment at AASLD Meeting

Boehringer Ingelheim announced results from a Phase Ib study, SOUND-C1, that showed the combination of two oral hepatitis C virus (HCV) compounds, the protease inhibitor BI 201335 and the polymerase inhibitor BI 207127, with ribavirin reduced viral load to the lower limit of quantifiable levels in HCV treatment-naïve patients.

Scientists to use CRISPR gene-editing technology for Phase 1 vaccine trials in humans

Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States

Eli Lilly to publish grant and contribution information

Eli Lilly and Company has announced that it will begin posting online all educational grant funding and other monetary contributions provided to U.S.-based organizations.

UC researchers offer more insights into how lack of gut bacteria influences fat absorption

A study led by University of Cincinnati lipid metabolism researchers lends additional insight into how bacteria in the gut, or lack thereof, influences intestinal mast cells (MMC) activation and perhaps fat absorption.

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

While the benefits of androgen ablation therapy have been well documented in patients with locally advanced and metastatic prostate cancer, there is a paucity of evidence its role in patients with low-grade, low-stage disease.

Read more Medical News

› Verified 3 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Fair Meadow Nursing Home are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Fair Meadow Nursing Home give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Boehringer to present data of SOUND-C1 Phase Ib study for HCV treatment at AASLD Meeting

Boehringer Ingelheim announced results from a Phase Ib study, SOUND-C1, that showed the combination of two oral hepatitis C virus (HCV) compounds, the protease inhibitor BI 201335 and the polymerase inhibitor BI 207127, with ribavirin reduced viral load to the lower limit of quantifiable levels in HCV treatment-naïve patients.

Scientists to use CRISPR gene-editing technology for Phase 1 vaccine trials in humans

Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States

Eli Lilly to publish grant and contribution information

Eli Lilly and Company has announced that it will begin posting online all educational grant funding and other monetary contributions provided to U.S.-based organizations.

UC researchers offer more insights into how lack of gut bacteria influences fat absorption

A study led by University of Cincinnati lipid metabolism researchers lends additional insight into how bacteria in the gut, or lack thereof, influences intestinal mast cells (MMC) activation and perhaps fat absorption.

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

While the benefits of androgen ablation therapy have been well documented in patients with locally advanced and metastatic prostate cancer, there is a paucity of evidence its role in patients with low-grade, low-stage disease.

Read more Medical News

› Verified 3 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines1
Total Amount of Fines in Dollars$22100
Number of Payment Denials0
Total Number of Penalties1

Patients' Stay Experience:

The resident survey data of Fair Meadow Nursing Home is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percentage of long-stay residents whose need for help with daily activities has increased12.0814.46
Percentage of long-stay residents who lose too much weight6.165.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder64.4448.41
Percentage of long-stay residents with a catheter inserted and left in their bladder01.79
Percentage of long-stay residents with a urinary tract infection2.612.65
Percentage of long-stay residents who have depressive symptoms12.935.05
Percentage of long-stay residents who were physically restrained2.550.23
Percentage of long-stay residents experiencing one or more falls with major injury1.913.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine10093.87
Percentage of long-stay residents who received an antipsychotic medication15.3814.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine97.2283.88